Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Mar 1;177(3):783–790. doi: 10.1084/jem.177.3.783

Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules

PMCID: PMC2190941  PMID: 8436909

Abstract

We have tested the hypothesis that phenotypic changes of development are accompanied by expression of differentiation-stage specific peptides bound to major histocompatibility complex (MHC) class I molecules. The U937 cell line, when cultured in the presence of phorbol myristate acetate (PMA), undergoes differentiation from monoblasts to macrophage-like cells. The high-performance liquid chromatography profile of peptides eluted from purified human histocompatibility leukocyte antigen class I molecules expressed by U937 treated with PMA differs from that obtained from control, untreated U937 cells. Chemical sequencing of eluted peptides identified a peptide derived from cytomegalovirus in both treated and untreated cells. PMA-treated, but not untreated cells, displayed an additional peptide derived from interleukin 1 beta. Hence, differentiation-induction of U937 is accompanied by the presentation of at least one differentiation-stage specific peptide. Our results indicate that, similar to viral infection, cellular development and transformation is accompanied by the de novo synthesis of proteins which are processed and presented on MHC class I molecules.

Full Text

The Full Text of this article is available as a PDF (918.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnstable C. J., Bodmer W. F., Brown G., Galfre G., Milstein C., Williams A. F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978 May;14(1):9–20. doi: 10.1016/0092-8674(78)90296-9. [DOI] [PubMed] [Google Scholar]
  2. Brodsky F. M., Guagliardi L. E. The cell biology of antigen processing and presentation. Annu Rev Immunol. 1991;9:707–744. doi: 10.1146/annurev.iy.09.040191.003423. [DOI] [PubMed] [Google Scholar]
  3. Carinci V., Guida S., Fontana M. R., Palla E., Rossini M., Melli M. Processing of interleukin-1 in cells of monocytic lineage is differentiation-dependent. Eur J Biochem. 1992 Apr 1;205(1):295–301. doi: 10.1111/j.1432-1033.1992.tb16780.x. [DOI] [PubMed] [Google Scholar]
  4. Falk K., Rötzschke O., Stevanović S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991 May 23;351(6324):290–296. doi: 10.1038/351290a0. [DOI] [PubMed] [Google Scholar]
  5. Garrido F., Ruiz-Cabello F. MHC expression on human tumors--its relevance for local tumor growth and metastasis. Semin Cancer Biol. 1991 Feb;2(1):3–10. [PubMed] [Google Scholar]
  6. Harris P. E., Gutierrez M. C., Reed E., King D. W., Suciu-Foca N. Biosynthesis and partial amino acid sequence of the human NDA4 antigen. An activation antigen common to B and T cell lineages. J Immunol. 1991 Aug 15;147(4):1299–1306. [PubMed] [Google Scholar]
  7. Harris P. E., Ralph P., Litcofsky P., Moore M. A. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. Cancer Res. 1985 Jan;45(1):9–13. [PubMed] [Google Scholar]
  8. Harris P. E., Strba-Cechova K., Rubinstein P., Mann D., King D. W., Suciu-Foca N. Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome. J Clin Invest. 1990 Mar;85(3):746–756. doi: 10.1172/JCI114500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol. 1985 Apr;37(4):407–422. doi: 10.1002/jlb.37.4.407. [DOI] [PubMed] [Google Scholar]
  10. Harris P., Reed E., King D. W., Suciu-Foca N. In vitro studies of the effect of MAb NDA 4 linked to toxin on the proliferation of a human EBV-transformed lymphoblastoid B cell line and of gibbon MLA leukemia cell line. Cell Immunol. 1991 Apr 15;134(1):85–95. doi: 10.1016/0008-8749(91)90333-7. [DOI] [PubMed] [Google Scholar]
  11. Hass R., Lonnemann G., Männel D., Topley N., Hartmann A., Köhler L., Resch K., Goppelt-Strübe M. Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells. Leuk Res. 1991;15(5):327–339. doi: 10.1016/0145-2126(91)90008-h. [DOI] [PubMed] [Google Scholar]
  12. Hunt D. F., Henderson R. A., Shabanowitz J., Sakaguchi K., Michel H., Sevilir N., Cox A. L., Appella E., Engelhard V. H. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science. 1992 Mar 6;255(5049):1261–1263. doi: 10.1126/science.1546328. [DOI] [PubMed] [Google Scholar]
  13. Hunt D. F., Michel H., Dickinson T. A., Shabanowitz J., Cox A. L., Sakaguchi K., Appella E., Grey H. M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 1992 Jun 26;256(5065):1817–1820. doi: 10.1126/science.1319610. [DOI] [PubMed] [Google Scholar]
  14. Jardetzky T. S., Lane W. S., Robinson R. A., Madden D. R., Wiley D. C. Identification of self peptides bound to purified HLA-B27. Nature. 1991 Sep 26;353(6342):326–329. doi: 10.1038/353326a0. [DOI] [PubMed] [Google Scholar]
  15. Kilpatrick B. A., Huang E. S., Pagano J. S. Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol. 1976 Jun;18(3):1095–1105. doi: 10.1128/jvi.18.3.1095-1105.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. March C. J., Mosley B., Larsen A., Cerretti D. P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grabstein K. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 1985 Jun 20;315(6021):641–647. doi: 10.1038/315641a0. [DOI] [PubMed] [Google Scholar]
  17. Monaco J. J. A molecular model of MHC class-I-restricted antigen processing. Immunol Today. 1992 May;13(5):173–179. doi: 10.1016/0167-5699(92)90122-N. [DOI] [PubMed] [Google Scholar]
  18. Neale M. L., Fiera R. A., Matthews N. Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer. 1990 Jan 15;45(1):203–208. doi: 10.1002/ijc.2910450136. [DOI] [PubMed] [Google Scholar]
  19. Parham P., Barnstable C. J., Bodmer W. F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol. 1979 Jul;123(1):342–349. [PubMed] [Google Scholar]
  20. Reed E., Hardy M., Benvenisty A., Lattes C., Brensilver J., McCabe R., Reemstma K., King D. W., Suciu-Foca N. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med. 1987 Jun 4;316(23):1450–1455. doi: 10.1056/NEJM198706043162305. [DOI] [PubMed] [Google Scholar]
  21. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 1990 May;9(5):1503–1510. doi: 10.1002/j.1460-2075.1990.tb08268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rudensky AYu, Preston-Hurlburt P., Hong S. C., Barlow A., Janeway C. A., Jr Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991 Oct 17;353(6345):622–627. doi: 10.1038/353622a0. [DOI] [PubMed] [Google Scholar]
  23. Rötzschke O., Falk K., Deres K., Schild H., Norda M., Metzger J., Jung G., Rammensee H. G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 1990 Nov 15;348(6298):252–254. doi: 10.1038/348252a0. [DOI] [PubMed] [Google Scholar]
  24. Suciu-Foca N., Cai J. D., Gutiérrea C., Reed E., Morrison S., Pernis B., King D. W. New differentiation antigens associated with the growth and maturation of B lymphocytes. J Immunol. 1988 Jan 15;140(2):395–403. [PubMed] [Google Scholar]
  25. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  26. Takács L., Kovacs E. J., Smith M. R., Young H. A., Durum S. K. Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse. J Immunol. 1988 Nov 1;141(9):3081–3095. [PubMed] [Google Scholar]
  27. Tenney D. J., Morahan P. S. Differentiation of the U937 macrophage cell line removes an early block of HSV-1 infection. Viral Immunol. 1991 Summer;4(2):91–102. doi: 10.1089/vim.1991.4.91. [DOI] [PubMed] [Google Scholar]
  28. Townsend A., Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 1989;7:601–624. doi: 10.1146/annurev.iy.07.040189.003125. [DOI] [PubMed] [Google Scholar]
  29. Van Bleek G. M., Nathenson S. G. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature. 1990 Nov 15;348(6298):213–216. doi: 10.1038/348213a0. [DOI] [PubMed] [Google Scholar]
  30. Weston K., Barrell B. G. Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. J Mol Biol. 1986 Nov 20;192(2):177–208. doi: 10.1016/0022-2836(86)90359-1. [DOI] [PubMed] [Google Scholar]
  31. von Boehmer H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol. 1990;8:531–556. doi: 10.1146/annurev.iy.08.040190.002531. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES